Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Sleep Disturbance During Opioid Tapering
NCT03789214Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jul 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of suvorexant in sleep disorder and opioid withdrawal, sponsored by Johns Hopkins University. Started Jul 2019; status: completed.
02
Drugs
suvorexant
03
Conditions
sleep disorderopioid withdrawal
Beyond the preview
Go deeper on NCT03789214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789214.